By analysing gene expression data from BL transcriptome sequencing projects, six biomarkers (ADAMTSL4, SEMA5B, ADAMTS15, THBS2, SPON1 and THBS1) were identified as possible indicators for diagnostic and prognostic targets for BL management. This evidence concerns the gene SEMA5B and Burkitt lymphoma.